CannabIP: U.S. Patent No. 10,132,564 B1

Cannabis IP patent

U.S. Patent No. 10,132,564 B1 (‘564) issued on November 20, 2018, for “Plant Dryer with Improved Convection Flow.”  It was issued to applicant/inventor Harvey Romanek of Seminole, Florida.  The assignee is THC Therapeutics, Inc..  THC Therapeutics is a publicly-traded cannabis tech company.  The ‘564 patent specifically encompasses their DHYDRONATOR® plant dryer product. Figure 1 illustrates …

Continue Reading

CannabIP: U.S. Patent No. 10,098,867 B2

Cannabis IP patent

U.S. Patent No. 10,098,867 B2 (‘867) issued on October 16, 2018, for “Use of Phytocannabinoids in the Treatment of Ovarian Carcinoma.”  It was issued to applicant GW Research Ltd. of Cambridge, Great Britain, the research division of the cannabinoid-based pharmaceutical company GW Pharmaceuticals, plc.  The inventors are Farideh Afshin Javid of Huddersfield, Great Britain, Marnie …

Continue Reading

CannabIP: U.S. Patent No. 10,117,891 B2

Cannabis IP patent

U.S. Patent No. 10,117,891 B2 (‘891) issued on November 6, 2018, for “Cannabinoid Composition for Treating Pain.”  It was issued to inventors Ramachandra Mukunda of Potomac, Maryland, and Ranga Chelva Krishna of Englewood, New Jersey.  The applicant/assignee is India Globalization Capital, Inc., a consolidated multi-industry company with a business division focused on cannabis pharmaceutical research. …

Continue Reading

CannabIP: U.S. Patent No. 10,011,804 B2

Cannabis IP patent Tech Patents

U.S. Patent No. 10,011,804 B2 (‘804) issued on July 3, 2018, for “Method of Extracting CBD, THC, and Other Compounds From Cannabis Using Controlled Cavitation.”  It was issued to inventor Douglas G. Mancosky of White, Georgia.  The applicant is Hydro Dynamics, Inc., a cross-industry cavitation extraction company located in Rome, Georgia.  The assignee is EcoXtraction, …

Continue Reading

CannabIP: U.S. Patent No. 10,039,740 B2

Cannabis IP patent

U.S. Patent No. 10,039,740 B2 (‘740) issued on August 7, 2018, for “Therapeutic Combinations of Sesquiterpenes and Flavonoids.”  It was issued to inventor Masayoshi Yamaguchi of Shizuoka, Japan.  The applicant/assignee is Primus Pharmaceuticals, Inc. of Scottsdale, Arizona, a pharmaceutical company which focuses on nutrition-based drug research. The ‘740 claims are directed to a composition of …

Continue Reading